![](/img/cover-not-exists.png)
Clinical Phase II Study of Pegylated Liposomal Doxorubicin as Second-Line Treatment in Disseminated Melanoma
Fink, W., Zimpfer-Rechner, C., Thoelke, A., Figl, R., Kaatz, M., Ugurel, MS., Schadendorf, D.Volume:
27
Year:
2004
Journal:
Onkologie
DOI:
10.1159/000081335
File:
PDF, 68 KB
2004